Evidence map›Paper›PMID 39041035›Full record

ArticleResearch square2024

Trained Immunity Generated by the Recombinant Zoster Vaccine.

Adriana Weinberg, Michael Johnson, Megan Crotteau, Debashis Ghosh, Thao Vu, Myron J Levin

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Adriana WeinbergUniversity of Colorado Denver | Anschutz Medical Campus.ORCID 0000-0001-6920-0623
Michael JohnsonUniversity of Colorado Denver.
Megan CrotteauUniversity of Colorado Denver.
Debashis GhoshUniversity of Colorado Denver.
Thao VuUniversity of Colorado Denver.
Myron J LevinUniversity of Colorado Denver.

Funding

PERSISTENCE OF PROTECTION CONFERRED BY SHINGRIX AGAINST HERPES ZOSTER IN OLDER ADULTSU01AI141919 · NIAID · UNIVERSITY OF COLORADO DENVER · PI ADRIANA WEINBERG · 2019 to 2026
$5.8M
NIAID NIH HHS U01 AI141919
6 · The paper itself

Abstract

Trained immunity may play a role in vaccine-induced protection against infections. We showed that the highly efficacious recombinant VZV-gE zoster vaccine (RZV) generated trained immunity in monocytes, natural killer (NK) cells, and dendritic cells (DCs) and that the less efficacious live zoster vaccine did not. RZV stimulated ex vivo gE-specific monocyte, DC and NK cell responses that did not correlate with CD4 + T-cell responses. These responses were also elicited in purified monocyte and NK cell cocultures stimulated with VZV-gE and persisted above prevaccination levels for ≥ 4 years post-RZV administration. RZV administration also increased ex vivo heterologous monocyte and NK cell responses to herpes simplex and cytomegalovirus antigens. ATAC-seq analysis and ex vivo TGFβ1 supplementation and inhibition experiments demonstrated that decreased

Indexed as

adaptive NK cellsmonocyte immunologic memoryolder adultsrecombinant zoster vaccinetrained immunityzosterzoster vaccines

Identifiers

PMID39041035
PMCPMC11261968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.